Figure 2 shows the clinical-pathological features of the 15 PDCs and 35 ATCs investigated as well as the distribution of BRAF, RAS (H-, K-, and N-RAS), and PIK3CA mutations. This evidence concerns the gene PIK3CA and Ehlers-Danlos syndrome, musculocontractural type.